The BIOENSIS 2D/3D Tumor Cell Line Profiling Service offers a streamlined and systematic approach to screening anti-cancer agents against tumor-derived cell lines. This service effectively evaluates efficacy and identifies biomarker associations. Our 2D and 3D cultures are grown under physiologically relevant conditions, enhancing the prediction of in vivo activity. This allows for the confident selection of promising drug candidates for further testing, minimizing the risk of costly setbacks.
Key assay features:
• Panels of up to 150 tumor cell lines for 2D/3D profiling, ensuring broad cancer type and subtype representation
• Combination or single-agent screens are performed in quadruplicate at nine concentrations
• Models tested in automated 384-well format
• Precision IC50, EC50, and GI50 results
• Available in 2D and 3D cultures
Please contact us to discuss your study and an up to date list of available cell lines
info@bioensis.com
